lysophosphatidic acid has been researched along with Bone Loss, Osteoclastic in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caeiro, JR; Conde, C; Gómez-Reino, JJ; González, A; Guede, D; Martínez, P; Orosa, B | 1 |
| Lee, BS; McMichael, BK; Meyer, SM | 1 |
| Chung, WY; Hwang, YS; Lee, SK; Park, KK | 1 |
| Bordet, JC; Boucharaba, A; Clézardin, P; Grès, S; Guglielmi, J; Peyruchaud, O; Saulnier-Blache, JS; Serre, CM | 1 |
4 other study(ies) available for lysophosphatidic acid and Bone Loss, Osteoclastic
| Article | Year |
|---|---|
Effect of lysophosphatidic acid receptor inhibition on bone changes in ovariectomized mice.
Topics: Animals; Bone and Bones; Bone Remodeling; Bone Resorption; Calcification, Physiologic; Cell Differentiation; Disease Models, Animal; Female; Femur; Humans; Immunoenzyme Techniques; Isoxazoles; Lysophospholipids; Mice; Mice, Inbred C57BL; Osteoblasts; Osteoclasts; Osteoporosis; Osteoporosis, Postmenopausal; Ovariectomy; Propionates; Receptors, Lysophosphatidic Acid; Signal Transduction; X-Ray Microtomography | 2015 |
c-Src-mediated phosphorylation of thyroid hormone receptor-interacting protein 6 (TRIP6) promotes osteoclast sealing zone formation.
Topics: Adaptor Proteins, Signal Transducing; Animals; ATPases Associated with Diverse Cellular Activities; Bone Resorption; Cell Fusion; CSK Tyrosine-Protein Kinase; LIM Domain Proteins; Lysophospholipids; Mice; Osteoclasts; Phosphorylation; Proteasome Endopeptidase Complex; Protein-Tyrosine Kinases; src-Family Kinases; Transcription Factors | 2010 |
Secretion of IL-6 and IL-8 from lysophosphatidic acid-stimulated oral squamous cell carcinoma promotes osteoclastogenesis and bone resorption.
Topics: Animals; Biological Assay; Blotting, Western; Bone Neoplasms; Bone Resorption; Carcinoma, Squamous Cell; Humans; Interleukin-6; Interleukin-8; Lysophospholipids; Mice; Mouth Neoplasms; Osteoclasts; RANK Ligand; Reverse Transcriptase Polymerase Chain Reaction | 2012 |
Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer.
Topics: Animals; Blood Platelets; Bone and Bones; Bone Neoplasms; Bone Resorption; Breast Neoplasms; Cell Line; Cell Line, Tumor; Cell Proliferation; Cricetinae; Culture Media; Cytokines; Disease Progression; Dose-Response Relationship, Drug; Doxycycline; Enzyme-Linked Immunosorbent Assay; Female; Humans; Immunohistochemistry; Interleukin-6; Interleukin-8; Ki-67 Antigen; Lysophospholipids; Mice; Mice, Inbred BALB C; Mice, Nude; Mitogens; Models, Biological; Neoplasm Metastasis; Osteoclasts; Osteolysis; Phospholipase D; Platelet Activation; Platelet Aggregation; Reverse Transcriptase Polymerase Chain Reaction; RNA; Time Factors; Transfection | 2004 |